Long COVID: An approach to clinical assessment and management in primary care

Long COVID is an emerging public health threat, following swiftly behind the surges of acute infection over the course of the COVID-19 pandemic. It is estimated that there are already approximately 100 million people suffering from Long COVID globally, 0.5 million of whom are South African, and for whom our incomplete understanding of the condition has forestalled appropriate diagnosis and clinical care. There are several leading postulates for the complex, multi-mechanistic pathogenesis of Long COVID. Patients with Long COVID may present with a diversity of clinical phenotypes, often with significant overlap, which may exhibit temporal heterogeneity and evolution. Post-acute care follow-up, targeted screening, diagnosis, a broad initial assessment and more directed subsequent assessments are necessary at the primary care level. Symptomatic treatment, self-management and rehabilitation are the mainstays of clinical care for Long COVID. However, evidence-based pharmacological interventions for the prevention and treatment of Long COVID are beginning to emerge. This article presents a rational approach for assessing and managing patients with Long COVID in the primary care setting.

Vitamin D status and COVID-19 severity

Background: Age, body mass index (BMI) and pre-existing comorbidities are known risk factors of severe coronavirus disease 2019 (COVID-19). In this study we explore the relationship between vitamin D status and COVID-19 severity. Methods: We conducted a prospective, cross-sectional descriptive study. We enrolled 100 COVID-19 positive patients admitted to a tertiary level hospital in Johannesburg, South Africa. Fifty had symptomatic disease (COVID-19 pneumonia) and 50 who were asymptomatic (incidental diagnosis). Following written informed consent, patients were interviewed regarding age, gender and sunlight exposure during the past week, disease severity, BMI, calcium, albumin, magnesium and alkaline phosphatase levels. Finally, blood was collected for vitamin D measurement. Results: We found an 82% prevalence rate of vitamin D deficiency or insufficiency among COVID-19 patients. Vitamin D levels were lower in the symptomatic group (18.1 ng/mL ± 8.1 ng/mL) than the asymptomatic group (25.9 ng/mL ± 7.1 ng/mL) with a p-value of 0.000. The relative risk of symptomatic COVID-19 was 2.5-fold higher among vitamin D deficient patients than vitamin D non-deficient patients (confidence interval [CI]: 1.14­3.26). Additional predictors of symptomatic disease were older age, hypocalcaemia and hypoalbuminaemia. Using multiple regression, the only independent predictors of COVID-19 severity were age and vitamin D levels. The patients exposed to less sunlight had a 2.39-fold increased risk for symptomatic disease compared to those with more sunlight exposure (CI: 1.32­4.33). Conclusion: We found a high prevalence of vitamin D deficiency and insufficiency among patients admitted to hospital with COVID-19 and an increased risk for symptomatic disease in vitamin D deficient patients.

Les syndromes coronariens aigus chez les patients COVID-19: à propos de trois cas au Centre Hospitalier Universitaire de Libreville, au Gabon / Acute coronary syndromes in COVID-19 patients : about three cases in the Libreville University Hospital Center, in Gabon

Introduction : Les thromboses artérielles, notamment coronaires, font partie des nombreuses manifestations extrapulmonaires de l'infection au coronavirus SARSCoV-2 dans les pays industrialisés. Cas cliniques: Ce travail rapporte trois observations de patients hospitalisés au Centre Hospitalier Universitaire de Libreville pour lesquels un diagnostic de syndrome coronarien aigu avait été retenu dans un contexte de Covid-19 durant la période allant du 1er mai au 30 septembre 2020. La première rapporte l'échec d'une thrombolyse avec la formation précoce d'un thrombus intraventriculaire gauche chez un patient de 59 ans ayant présenté un syndrome coronaire aigu antérieur étendu. Cette évolution particulière témoigne du caractère hautement inflammatoire et prothrombogène de la Covid-19. Les deux autres observations mettent l'accent sur les présentations parfois atypiques et les difficultés diagnostiques des syndromes coronariens aigus dans cette situation à Libreville. Conclusion : Le diagnostic et la prise en charge des syndromes coronariens aigus sont complexes dans le contexte d'infection à SARSCoV-2 dans nos régions

Introduction: Arterial thrombosis, particularly coronary thrombosis, is one of the many extrapulmonary manifestations of infection with the SARSCoV-2 coronavirus in industrialized countries. Clinical cases: This work reports three observations of patients hospitalized at the Center Hospitalier Universitaire de Libreville for whom a diagnosis of acute coronary syndrome had been made in Covid-19 during the period from May 1 to September 30, 2020. The first reports a thrombolysis failure with early formation of a left intraventricular thrombus in a 59-year-old patient with extensive anterior acute coronary syndrome. This particular evolution demonstrates the highly inflammatory and prothrombogenic context of Covid-19.The other two observations focus on the atypical presentations and the diagnostic difficulties of acute coronary syndromes in this infectious atmosphere in Libreville. Conclusion: The diagnosis and management of acute coronary syndromes are difficult in the context of SARSCoV-2 infection in our regions.

Self-medication against COVID-19 in health workers in Conakry, Guinea

Data regarding the prevalence and consequences of self-medication during the COVID-19 pandemic in Africa are very limited. The study aimed to explore the frequency and risk factors of self-medication against COVID-19 by health personnel in this study. This cross-sectional study took place in June 2021, in Conakry, in the all three national hospitals and the six community medical centers, and five primary health centers. A multivariate logistic regression model was performed to identify factors associated with self-medication. A total of 975 health workers with a median age of 31 (IQR: 27-40) years, with 504 (51.7%) women were included. The majority were clinicians: physicians (33.1%) or nurses (33.1%). Of all, 46.2% reported having had at least one COVID-19 symptom during the 12 months preceding the survey. The proportion of self-medication was 15.3% among national hospital staff, 12.20% in municipality medical centers and 22.6% in primary health centers (p=0.06). More than two-thirds (68.7%) who selfmedicated did not have a test for SARSCoV- 2 infection. They took antibiotics including azithromycin, amoxicillin, ampicillin (42.2%), acetaminophen (37.4%), vitamin C (27.9%), hydroxychloroquine (23.8%) and medicinal plants (13.6%). The median duration of self-medication was 4 days. Fatigue or asthenia, sore throat, loss of smell and sore throat of a close person were independently associated with selfmedication. Health care workers largely practiced self-medication during the Covid pandemic and without diagnostic testing. The results suggest the need for training and sensitization of medical personnel to avoid the consequences of the molecules used, including hepatotoxicity and antibiotic resistance

Validation of the COVID-19 IgG/IgM Rapid Test Cassette (BNCP ­ 402 and BNCP402) in a South African setting

Background: Different diagnostic tools could improve early detection of coronavirus disease 2019 (COVID-19). A number of antibody-based serological point-of-care tests have been developed to supplement real-time reverse transcriptase polymerase chain reaction (RT-PCR)-based diagnosis. This study describes the validity of an antibody test, namely the immunoglobulin G (IgG)/immunoglobulin M (IgM) Rapid Test Cassette® (BNCP ­ 402 and BNCP402), manufactured by Spring Healthcare Services. Methods: A prospective cohort validation study was undertaken at Chris Hani Baragwanath Academic Hospital between 16 July 2020 and 12 August 2020. A total of 101 patients admitte as COVID-19 cases under investigation were included in the study. They were divided into two categories depending on time since symptom onset: testing performed within seven days (early cohort) and after seven days (late cohort). The rapid antibody test was compared to the RT-PCR. Results: Overall, the test has a sensitivity and specificity of 85.2% and 80.0%, respectively, for a combination of IgG and IgM. Sensitivity and specificity of IgG testing alone were 81.5% and 85%. Sensitivity improved for testing with increasing time from symptom onset; however, specifity was not significantly different. Conclusion: The study data adds to the body of evidence that because of relatively low sensitivity and specificity, there is a limited role for antibody-based point-of-care testing in the acute phase of COVID-19 infection, as was the case with this IgG/IgM Rapid Test Cassette (BNCP ­ 402 and BNCP402). There may exist a role for such testing in patients recovered from prior COVID-19 infection or in seroprevalence studies; however, additional evaluations at later timepoints from symptom onset are required.

Profil épidémiologique de la COVID-19 dans la région de Tombouctou au Mali / Epidemiological profile of COVID-19 in Tombouctou region in Mali

Introduction : L'objectif de notre étude était d'établir le profil épidémiologique de la COVID-19 à Tombouctou. Matériel et méthodes : Il s'agissait d'une étude transversale descriptive des données de surveillance de la COVID-19 de la Région de Tombouctou du 3 avril au 1er octobre 2020. Nos variables d'intérêts ont été extraites de la base de données de surveillance et analysées sur Excel 2013. Les fréquences, taux et ratio ont été calculés. Résultats :Au total 1851 cas suspects en provenance de tous les districts de la région ont été testés à la RT-PCR dont 572 confirmés soit un taux de positivité de 30,90%. La tranche d'âge de 15-34 ans était la plus représentée avec une proportion de 48% de l'effectif des confirmés. Le sex ratio (homme/femme) des cas confirmés était de 2,67. La ville de Tombouctou était l'épicentre de la COVID-19. La région de Tombouctou avait un taux de dépistage d'environ 2‰ (1851/928.000) et a connu son pic entre les semaines 22 et 23 avec une létalité de 2,8%. Conclusion : Les jeunes et les hommes seraient les plus susceptibles d'être infectés par la COVID-19. Nous recommandons le renforcement de la sensibilisation pour le respect des mesures barrières

Introduction: The objective of our study was to establish the epidemiological profile of COVID-19 in Tombouctou. Material and methods: This was a descriptive cross-sectional study of COVID-19 surveillance data from Tombouctou from April 3 to October 1, 2020. Our variables of interest were extracted from the surveillance database and analyzed with Excel 2013. The frequencies, rate, and ratio were computed. Results: Overall, 1851 suspects from all districts of the region were screened by RT-PCR, including 572 confirmed, which indicate a positivity rate of 30.90%. The 15-34 age group was the most represented with 48% of the confirmed cases. The sex ratio (male / female) of confirmed cases was 2.67. The city of Tombouctou was the epicenter of COVID-19. The Tombouctou region had a detection rate of around 2‰ (1851/928,000) and peaked between weeks 22 and 23 with a case fatality of 2.8%. Conclusion: Young people and men were most likely to be infected with COVID-19. We recommend increasing awareness of compliance with barrier measures.

Pre-evaluation assessment of serological-based COVID-19 point-of-care lateral flow assays in Kenya

Background: Timely testing is a key determinant of management outcomes of coronavirus disease 2019 (COVID-19). Real-time reverse transcription polymerase chain reaction tests are currently the mainstay for COVID-19 testing. However, serological point-of-care tests (PoCTs) can be useful in identifying asymptomatic and recovered cases, as well as herd immunity. Objective: The aim of this study was to assess COVID-19 PoCTs in Kenya to support the emergency use authorisation of these tests. Methods: Between March 2020 and May 2020, 18 firms, of which 13 were from China, submitted their PoCTs to the national regulatory authority, the Pharmacy and Poison Board, who in turn forwarded them to the Kenya Medical Research Institute for pre-evaluation assessment. The tests were run with real-time reverse transcription polymerase chain reaction COVID-19-positive samples. Pre-COVID-19 plasma samples that were collected in June 2019were used as negative samples. The shelf lives of the PoCTs ranged from 6 to 24 months. Results: Only nine (50%) tests had sensitivities ≥ 40% (range: 40% ­ 60%) and the ability of these tests to detect IgM ranged from 0% to 50%. Many (7/18; 38.9%) of the kits had very weak IgM and IgG band intensities (range: 2­3). Conclusion: Serological-based PoCTs available in Kenya can only detect COVID-19 in up to 60% of the infected population.

COVID-19 Health Knowledge and Practices among Nigerian Residents during the Second Wave of the Pandemic: A quick online cross-sectional survey

The COVID-19 pandemic has redefined life as a whole. The lack of knowledge about the safe practices needed to manage the spread of the global pandemic could be detrimental to public health. This dearth of knowledge and inappropriate practices could increase the spread of the coronavirus and lead to high mortality rates in a country like Nigeria where access to healthcare services is limited. The study's objective was to assess the health knowledge and practices of Nigerian residents in the face of the second wave of the COVID-19 pandemic. MATERIALS AND METHODS The study adopted a cross-sectional online survey which was conducted from January 2 to February 1, 2021. A self-administered questionnaire was used to collect data on the socio-demographics characteristics of respondents, the knowledge of COVID-19 and health management practices related to the virus. The reliability of the instrument yielded 0.72 internal consistency and the data were analyzed using descriptive and logistic regression at p<0.05. RESULTS A total of 1,988 respondents participated in the study; 49.3% of this number were urban residents, 63.0% were males, 58.1% were married, and 67.4% had tertiary education. Overall, the mean score was 9.44±1.8 (72.6%) for knowledge and 6.72±3.1 (56%) for appropriate practices. Rural residence (OR = 0.552, 95% CI 0.351­0.868), female gender (OR = 4.494, 95% CI 3.264­6.187), aged 50 years and above (OR = 0.137, 95% CI 0.071-0.261), married status (OR = 5.004, 95% CI 3.242­7.724), tertiary education (OR = 7.049, 95% CI 4.362­ 11.391), Yoruba ethnicity (OR = 2.828, 95% CI 1.292­6.187), and good knowledge of COVID-19 (OR = 1.905, 95% CI 1.376­2.637) significantly predict appropriate practices. CONCLUSION A substantial number of our respondents had good knowledge but lacked appropriate practices towards COVID-19. The beliefs of the people influenced inappropriate practices just as adequate practice was associated with good African Journal of Health Sciences Volume 34, Issue No.4, July- August 2021 483 knowledge. There is a need for adequate sensitization programmes which might require the use of local languages/dialects and Nigerian Pidgin English to reduce the misinformation surrounding the virus.

SARS-CoV-2 detection among international air travellers to Ghana during mandatory quarantine

Objectives: To determine the prevalence of SARS-CoV-2 detection among international travellers to Ghana during mandatory quarantine. Design: A retrospective cross-sectional study. Setting: Air travellers to Ghana on 21st and 22nd March 2020. Participants: On 21st and 22nd March 2020, a total of 1,030 returning international travellers were mandatorily quarantined in 15 different hotels in Accra and tested for SARS-CoV-2. All of these persons were included in the study. Main outcome measure: Positivity for SARS-CoV-2 by polymerase chain reaction. Results: The initial testing at the beginning of quarantine found 79 (7.7%) individuals to be positive for SARS-CoV2. In the exit screening after 12 to 13 days of quarantine, it was discovered that 26 of those who tested negative for SARS-CoV-2 in the initial screening subsequently tested positive. Conclusions: Ghana likely averted an early community spread of COVID-19 through the proactive approach to quarantine international travellers during the early phase of the pandemic